Загрузка...
Drug therapy for hereditary cancers
Tumors arising in patients with hereditary cancer syndromes may have distinct drug sensitivity as compared to their sporadic counterparts. Breast and ovarian neoplasms from BRCA1 or BRCA2 mutation carriers are characterized by deficient homologous recombination (HR) of DNA, that makes them particula...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3171323/ https://ncbi.nlm.nih.gov/pubmed/21819606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1897-4287-9-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|